Literature DB >> 25639979

Universal cardiac induction of human pluripotent stem cells in two and three-dimensional formats: implications for in vitro maturation.

Miao Zhang1, Jan Sebastian Schulte, Alexander Heinick, Ilaria Piccini, Jyoti Rao, Roberto Quaranta, Dagmar Zeuschner, Daniela Malan, Kee-Pyo Kim, Albrecht Röpke, Philipp Sasse, Marcos Araúzo-Bravo, Guiscard Seebohm, Hans Schöler, Larissa Fabritz, Paulus Kirchhof, Frank Ulrich Müller, Boris Greber.   

Abstract

Directed cardiac differentiation of human pluripotent stem cells (hPSCs) enables disease modeling, investigation of human cardiogenesis, as well as large-scale production of cardiomyocytes (CMs) for translational purposes. Multiple CM differentiation protocols have been developed to individually address specific requirements of these diverse applications, such as enhanced purity at a small scale or mass production at a larger scale. However, there is no universal high-efficiency procedure for generating CMs both in two-dimensional (2D) and three-dimensional (3D) culture formats, and undefined or complex media additives compromise functional analysis or cost-efficient upscaling. Using systematic combinatorial optimization, we have narrowed down the key requirements for efficient cardiac induction of hPSCs. This implied differentiation in simple serum and serum albumin-free basal media, mediated by a minimal set of signaling pathway manipulations at moderate factor concentrations. The method was applicable both to 2D and 3D culture formats as well as to independent hPSC lines. Global time-course gene expression analyses over extended time periods and in comparison with human heart tissue were used to monitor culture-induced maturation of the resulting CMs. This suggested that hPSC-CMs obtained with our procedure reach a rather stable transcriptomic state after approximately 4 weeks of culture. The underlying gene expression changes correlated well with a decline of immature characteristics as well as with a gain of structural and physiological maturation features within this time frame. These data link gene expression patterns of hPSC-CMs to functional readouts and thus define the cornerstones of culture-induced maturation.
© 2015 AlphaMed Press.

Entities:  

Keywords:  cardiac differentiation; human pluripotent stem cells; in-vitro maturation

Mesh:

Year:  2015        PMID: 25639979     DOI: 10.1002/stem.1964

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  43 in total

1.  Three-Dimensional Adult Cardiac Extracellular Matrix Promotes Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

Authors:  Ashley H Fong; Mónica Romero-López; Christopher M Heylman; Mark Keating; David Tran; Agua Sobrino; Anh Q Tran; Hiep H Pham; Cristhian Fimbres; Paul D Gershon; Elliot L Botvinick; Steven C George; Christopher C W Hughes
Journal:  Tissue Eng Part A       Date:  2016-08       Impact factor: 3.845

2.  A human embryonic stem cell reporter line for monitoring chemical-induced cardiotoxicity.

Authors:  Su-Yi Tsai; Zaniar Ghazizadeh; Hou-Jun Wang; Sadaf Amin; Francis A Ortega; Zohreh Sadat Badieyan; Zi-Ting Hsu; Miriam Gordillo; Ritu Kumar; David J Christini; Todd Evans; Shuibing Chen
Journal:  Cardiovasc Res       Date:  2020-03-01       Impact factor: 10.787

Review 3.  Signaling Pathways and Gene Regulatory Networks in Cardiomyocyte Differentiation.

Authors:  Abhirath Parikh; Jincheng Wu; Robert M Blanton; Emmanuel S Tzanakakis
Journal:  Tissue Eng Part B Rev       Date:  2015-05-11       Impact factor: 6.389

4.  BMP and WNT: the road to cardiomyocytes is paved with precise modulation.

Authors:  Mattia Quattrocelli; Elizabeth M McNally
Journal:  Stem Cell Investig       Date:  2016-06-15

5.  Diffraction-based technology for the monitoring of contraction dynamics in 3D and 2D tissue models.

Authors:  Ronan Le Harzic; Ina Meiser; Julia C Neubauer; Iris Riemann; Michael Schiffer; Frank Stracke; Heiko Zimmermann
Journal:  Biomed Opt Express       Date:  2020-01-02       Impact factor: 3.732

6.  Controlled Release of Small Molecules for Cardiac Differentiation of Pluripotent Stem Cells.

Authors:  Christopher J Tsao; Francesca Taraballi; Laura Pandolfi; Aaron J Velasquez-Mao; Rodrigo Ruano; Ennio Tasciotti; Jeffrey G Jacot
Journal:  Tissue Eng Part A       Date:  2018-10-29       Impact factor: 3.845

7.  A synthetic DNA-binding inhibitor of SOX2 guides human induced pluripotent stem cells to differentiate into mesoderm.

Authors:  Junichi Taniguchi; Ganesh N Pandian; Takuya Hidaka; Kaori Hashiya; Toshikazu Bando; Kyeong Kyu Kim; Hiroshi Sugiyama
Journal:  Nucleic Acids Res       Date:  2017-09-19       Impact factor: 16.971

Review 8.  Perspectives and Challenges of Pluripotent Stem Cells in Cardiac Arrhythmia Research.

Authors:  Alexander Goedel; Ilaria My; Daniel Sinnecker; Alessandra Moretti
Journal:  Curr Cardiol Rep       Date:  2017-03       Impact factor: 2.931

9.  Effective Hypothermic Storage of Human Pluripotent Stem Cell-Derived Cardiomyocytes Compatible With Global Distribution of Cells for Clinical Applications and Toxicology Testing.

Authors:  Cláudia Correia; Alexey Koshkin; Madalena Carido; Nuno Espinha; Tomo Šarić; Pedro A Lima; Margarida Serra; Paula M Alves
Journal:  Stem Cells Transl Med       Date:  2016-03-29       Impact factor: 6.940

Review 10.  Human Induced Pluripotent Stem Cell (hiPSC)-Derived Cells to Assess Drug Cardiotoxicity: Opportunities and Problems.

Authors:  Tarek Magdy; Adam J T Schuldt; Joseph C Wu; Daniel Bernstein; Paul W Burridge
Journal:  Annu Rev Pharmacol Toxicol       Date:  2017-10-06       Impact factor: 13.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.